These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2217417)

  • 1. M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
    Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Darshaw D; Reuter V
    Prog Clin Biol Res; 1990; 353():179-86. PubMed ID: 2217417
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP; Zincke H; Hahn RG; Morgan WR
    Prog Clin Biol Res; 1990; 353():119-27. PubMed ID: 2217409
    [No Abstract]   [Full Text] [Related]  

  • 4. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
    Sternberg CN
    Prog Clin Biol Res; 1990; 353():143-52. PubMed ID: 2217412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of metastatic cancer of the bladder. Apropos of 50 patients treated with M-VAC].
    Beuzeboc P; Dhote R; Thiounn N; Flam T; Zerbib M; Debré B; Pouillart P
    Cancer Radiother; 1998 Apr; 2 Suppl 1():92s-96s. PubMed ID: 9749087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Watson RC; Hollander PS; Fair WR
    Prog Clin Biol Res; 1988; 260():481-5. PubMed ID: 3283768
    [No Abstract]   [Full Text] [Related]  

  • 7. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
    Chechile G; Montie J; Pontes JE; Bukowski RM
    Prog Clin Biol Res; 1990; 353():153-61. PubMed ID: 2217413
    [No Abstract]   [Full Text] [Related]  

  • 8. Organ conservation in deeply invasive bladder cancer.
    Fair WR
    Prog Clin Biol Res; 1991; 370():119-26. PubMed ID: 1924440
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].
    Bellmunt Molins J; Ribas A; Albanell J; Lorente Garín JA; de Torres Mateos JA; Morote Robles J; López Palacios MA; Banús Gassol JM; Casado Cobo S; Eres N; Solé Calvo LA
    Arch Esp Urol; 1996 Jun; 49(5):465-72. PubMed ID: 8766083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
    Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Nakatsu H; Kume T; Kodama M; Masu C
    Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
    Fukuda H; Mitsumori K; Minagawa S; Kumazawa T; Tadachi K; Iinuma M; Satoh S; Satoh K; Habuchi T; Kato T
    Hinyokika Kiyo; 2005 Feb; 51(2):113-6. PubMed ID: 15773365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
    Seguchi T; Nakano E; Miki T; Kondoh M; Nishimura K; Nakamura N; Okuyama A
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Place of chemotherapy in the treatment of invasive bladder tumors].
    Pariente JL; Theodore C; Davin JL; Rischmann P; Chopin D
    Prog Urol; 1999 Apr; 9(2):219-24. PubMed ID: 10370944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
    Simon SD; Srougi M
    Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy for invasive bladder cancer].
    Kageyama Y; Kihara K
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN; Yagoda A; Scher HI
    Prog Clin Biol Res; 1988; 277():45-51. PubMed ID: 3054909
    [No Abstract]   [Full Text] [Related]  

  • 20. Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle.
    Arias F; Dueñas M; Martínez E; Domínguez MA; Illarramendi JJ; Villafranca E; Tejedor M; Molina F; Meiriño R; Valerdi JJ
    Cancer; 1997 Jul; 80(1):115-20. PubMed ID: 9210716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.